Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-043763
Filing Date
2017-07-05
Accepted
2017-07-05 19:31:13
Documents
1
Period of Report
2017-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6052
  Complete submission text file 0001209191-17-043763.txt   7443
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SCHERING-PLOUGH CORPORATION 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
COX CARRIE SMITH (Reporting) CIK: 0001110753 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34912 | Film No.: 17950418